INTELLIGENT BIO SOLUTIONS INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $828.20 thousand as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-19
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $828.20K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $826.26K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $842.68K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $630.78K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $828.20K 10-K · filed 2026-08-19 |
| 2026-03-31 | $826.26K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $842.68K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $630.78K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $885.06K 10-K · filed 2025-08-15 |
| 2025-03-31 | $835.27K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $808.71K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $863.22K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $884.63K 10-K · filed 2024-09-18 |
| 2024-03-31 | $884.66K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $892.71K 10-Q · filed 2024-02-09 |
| 2023-09-30 | $855.93K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $884.42K 10-K · filed 2023-08-23 |
| 2023-03-31 | $895.60K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.18M 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |